US 8529811

I'll search for authoritative records on this patent number, including any current litigation activity.

Let me check specifically for any 2026 Federal Circuit activity and confirm the outcome of the prior appeals.

Summary — US Patent No. 8,529,811 B2

Important scope note: I searched for this exact number. I found no 2026 Court of Appeals for the Federal Circuit docket activity involving 8,529,811. The only Federal Circuit proceedings surfaced are from 2016–2017 and arise from ITC Investigation No. 337‑TA‑963 (appeals Nos. 16‑2175, 16‑2187, and AliphCom v. ITC, No. 17‑1381, the latter filed 12/20/2016 and closed 06/06/2017). I cannot confirm any pending 2026 litigation, and I would flag any claim of 2026 CAFC activity as unsupported unless separately verified.

Bibliographic data

Abstract (as issued)

"Techniques for component protective overmolding using protective external coatings include selectively applying a protective material substantially over one or more elements coupled to a framework configured to be worn, the elements including at least a sensor, and forming one or more moldings substantially over a subset or all of the framework, the protective material and the elements, after the protective material has been selectively applied, at least one of the one or more moldings having a protective property."

Independent claims in plain language

Claim 1 (three-molding embodiment) — A method with four ordered molding steps:

1. Selectively apply at least one covering over one or more of a set of elements coupled to a framework of a wearable device worn by a user, where the elements include at least a sensor;
2. Selectively form a first inner molding covering all or substantially all of the covering, the elements, and the framework;
3. Selectively form a second inner molding covering all or substantially all of the first inner molding; and
4. Selectively form an outer molding of the wearable device covering all or substantially all of the second inner molding, with the outer molding configured to contact the user.

Plain-language gist: protect delicate electronics with a selectively applied coating, then encapsulate everything in successive molded layers (two inner + one skin-contacting outer), so a defective outer layer can be stripped without scrapping the expensive sensor/electronics.

Claim 16 (broader, one-or-more inner moldings) — A method comprising:

1. Selectively applying at least one protective material over one or more of a set of elements coupled to a wearable-device framework, the elements including at least a sensor;
2. Forming one or more inner moldings substantially over a subset or all of the framework, protective material, and elements after the selective applying, where at least one inner molding has a protective property (e.g., waterproof, water-resistant, hydrophobic, oleophobic, or anti-bacterial per dependent claims 18–22); and
3. Forming an outer molding covering all or substantially all of the inner molding(s), configured to contact the user.

Note the distinction: claim 16 does not require two inner moldings (unlike claim 1), and it locates the "protective property" in the inner molding, whereas the dependent claims of claim 1 (2–7) locate the protective properties in the outer molding.

Dependent-claim highlights

• Outer molding properties (claims 2–7): anti-bacterial material; oleophobic material; UV-protective; hydrophobic; waterproof seal; surface pattern.
• Quality control (claims 8–9, 25): inspect the outer/inner molding for defects; if defective, remove and re-form it.
• Framework materials (claims 10–14): synthetic fiber; carbon fiber; one or more filaments; thermoplastic elastomer (e.g., polypropylene).
• Covering / protective material (claims 15, 26): a curable coating (the spec cites UV-curable Loctite® 5083).
• Claim 23: the protective material protects elements from damage occurring during formation of the inner molding(s).
• Claim 24: an inner molding comprises a medical-grade thermoplastic elastomer.

Litigation / administrative history (verified)

• ITC Inv. No. 337‑TA‑963 — Certain Activity Tracking Devices, Systems, and Components Thereof (family litigation; related CAFC appeals filed Dec. 2016).
• IPR2016‑00607 — Fitbit, Inc. v. AliphCom, filed Feb. 10, 2016; PTAB panel Crumbley, Abraham, Tornquist; Final Written Decision issued Aug. 15, 2017. (Sources: Docket Alarm; Unified Patents PTAB portal.)
• Renewal/ownership chain: AliphCom → security interests (DBD Credit Funding; Wells Fargo; Silver Lake Waterman; BlackRock) → JB IP Acquisition LLC (July 19, 2019) → J Fitness LLC liens.

Uncertainty / caveats

• I could not independently verify the outcome of the IPR2016‑00607 Final Written Decision (e.g., whether claims were cancelled or upheld) from the search results — that should be confirmed against the PTAB document itself before relying on it.
• The "current assignee" shown by Google Patents (JB IP Acquisition LLC) is expressly described by that source as possibly inaccurate; ownership is fragmented across recorded security interests, so treat the assignee entry as provisional.
• No evidence of 2026 CAFC or district court activity for this specific patent was found. If 2026 activity is the premise of the request, it is unconfirmed here.

Authoritative references: https://patents.google.com/patent/US8529811/en ; https://patentimages.storage.googleapis.com/bf/7c/ba/a971a7ee13ada3/US8529811.pdf ; https://www.docketalarm.com/search/?q=patent%3A%288529811%29 ; https://insight.rpxcorp.com/patent/[US8529811B2](/patent/US8529811B2)

I'll research litigation involving US Patent 8,529,811. Let me run several targeted searches.

Let me dig into the specific case details, including the ITC investigation, district court cases, and appeals.

Let me pin down the Federal Circuit appeals and the IPR final decision specifics.

Based on my searches of litigation databases (Docket Alarm, Justia, CourtListener, USITC Federal Register notices, and PTAB records), here is what I found for US Patent 8,529,811 specifically. I have restricted hits to this exact patent number and excluded the companion patents (e.g., 8,073,707; 8,398,546; 8,446,275; 8,793,522; 8,961,413) that were litigated alongside it, except where they help identify the same case.

Litigation involving US 8,529,811 ("the '811 patent")

1. ITC Investigation — Certain Activity Tracking Devices, Systems, and Components Thereof

• Complainants (plaintiffs): AliphCom d/b/a Jawbone (San Francisco, CA) and BodyMedia, Inc. (Pittsburgh, PA) — collectively "Jawbone"
• Respondents (defendants): Fitbit, Inc. (San Francisco, CA); Flextronics International Ltd. (Singapore / San Jose, CA); Flextronics Sales & Marketing (A-P) Ltd. (Port Louis, Mauritius)
• Jurisdiction: U.S. International Trade Commission (Section 337)
• Case number: Inv. No. 337-TA-963
• Filing date: Complaint filed July 7, 2015; investigation instituted August 21, 2015
• Status/outcome: The '811 patent was one of six patents asserted (along with trade-secret claims). The '811 allegations did not reach a merits determination — the ALJ granted Jawbone's unopposed motions to terminate as to claim 6 (Feb. 22, 2016) and as to the remaining '811 claims (Mar. 11, 2016). All patent claims, including '811, were terminated, leaving only trade secrets. On Aug. 23, 2016 the ALJ issued a final ID of no violation of Section 337 (no trade-secret misappropriation; no domestic-injury showing). The Commission determined not to review on Oct. 20, 2016, terminating the investigation. (Source: USITC Federal Register notices, 81 FR 74480 / 2016-25829.)

2. AliphCom d/b/a Jawbone and BodyMedia, Inc. v. Fitbit, Inc. (district court)

• Plaintiff(s): AliphCom (d/b/a Jawbone) and BodyMedia, Inc.
• Defendant(s): Fitbit, Inc.
• Jurisdiction/Court: U.S. District Court for the Northern District of California (San Francisco), Judge Haywood S. Gilliam, Jr.
• Case number: 3:15-cv-02579-HSG
• Filing date: June 10, 2015 (operative complaint July 3, 2015)
• Status/outcome: The '811 patent was among six patents asserted. The court stayed the action on Dec. 30, 2015 pending the parallel ITC investigation (Aliphcom v. Fitbit, Inc., 154 F. Supp. 3d 933 (N.D. Cal. 2015)). The case was later dismissed with prejudice by stipulation on Dec. 21, 2017. (Sources: Justia docket; CourtListener.)

3. Fitbit, Inc. v. AliphCom, Inc. d/b/a Jawbone (PTAB — inter partes review)

• Petitioner (plaintiff): Fitbit, Inc.
• Patent Owner (defendant): AliphCom, Inc. d/b/a Jawbone (assignee; later recorded under JB IP Acquisition LLC / J Fitness LLC)
• Jurisdiction: USPTO Patent Trial and Appeal Board
• Case number: IPR2016-00607
• Filing date: February 10, 2016
• Status/outcome: Review instituted Aug. 16, 2016 on claims 16–26. Final Written Decision issued Aug. 15, 2017, holding that Fitbit proved by a preponderance of the evidence that claims 16–26 of the '811 patent are unpatentable (anticipation by "Lo"; obviousness over Lo+Huang, Lo+Handbook of Thermoplastic Elastomers, and Lo+Toyoda). (Sources: PTAB Institution Decision and Final Written Decision, IPR2016-00607.)

4. Federal Circuit appeals (listed on the patent record)

The Google Patents family-litigation record for US 8,529,811 lists three Federal Circuit appeals: Nos. 16-2175, 16-2187, and 17-1381. I was not able to confirm from the search results which specific patent(s) or issues these appeals concerned, or their outcomes — they appear associated with this patent's litigation family (the Jawbone/Fitbit dispute and the related IPRs). Treat the linkage of these appeals specifically to the '811 patent as unverified pending direct PACER/CAFC docket review.

Caveats and items I could NOT confirm

• I found no district-court case in which the '811 patent reached a final merits judgment (infringement or validity) — its ITC claims were terminated early, the N.D. Cal. case was stayed then dismissed by stipulation, and its PTAB claims were cancelled.
• The later Fitbit, Inc. v. AliphCom matters (e.g., 5:16-cv-00118 (N.D. Cal.) and 3:17-cv-01139 (N.D. Cal.)) asserted Fitbit's own patents (U.S. 9,048,923; 9,026,053; 9,106,307) — not the '811 patent — so they are outside the scope of your request.
• I did not find any subsequent NPE-style assertions of the '811 patent by later assignees (JB IP Acquisition LLC or J Fitness LLC). The patent's recorded legal status is Expired – Fee Related, with anticipated expiration June 10, 2031.

If you need the specific bases and outcomes of Federal Circuit Nos. 16-2175, 16-2187, and 17-1381, or confirmation of any post-2019 assertion activity by the current assignee, those would require direct CAFC/PACER docket pulls, which my searches did not resolve.

I'll start by verifying what PTAB activity exists, since the patent page itself references an IPR that the ODP block says isn't indexed.

The patent page referenced an actual IPR. Let me dig into its details and check for related proceedings and appeals.

Proceedings overview

One AIA trial proceeding is on file for US 8,529,811 — IPR2016-00607 (Fitbit, Inc. v. AliphCom, Inc. d/b/a Jawbone), which invalidated claims 16–26 while claims 1–15 were never instituted and therefore remain untested — i.e., the patent is partially dead: the entire claim-16 line (16–26) has been canceled with a Final Written Decision on the merits, and the claim-1 line (1–15) survived the institution stage untouched. Flag on the source data: the "PTAB proceedings on file" ODP block states there are no AIA trials for this patent, but that is stale/incorrect — the proceeding is confirmed by the Board's own FWD (Paper 37), by Docket Alarm's docket, and by the litigation block on the patent's own Google Patents page ("PTAB case IPR2016-00607 filed (Final Written Decision)"). Defensively: if you are accused under claims 16–26, the patent has no case left; if you are accused under claims 1–15, the FWD gives you nothing directly, but it hands you the Board's own reasoning on the "covers all or substantially all" limitation plus a full record of art (Anderson/Downey and secondary references) that Fitbit never got substantively adjudicated.

IPR2016-00607 — Fitbit, Inc. v. AliphCom, Inc. d/b/a Jawbone

• Type: Inter Partes Review (35 U.S.C. §§ 311–318)

• Filed: 2016-02-10 (FWD: "On February 10, 2016, Fitbit requested an inter partes review of claims 1–26 of the '811 patent," Pet., Paper 2)

• Status: Final Written Decision issued — claims invalidated (as to claims 16–26); institution denied as to claims 1–15, rehearing denied. Current patent-level legal status per the patent record: "Expired - Fee Related."

• Judge panel: Christopher L. Crumbley (writing), Jon B. Tornquist, and Jeffrey W. Abraham, Administrative Patent Judges

• Petitioner's counsel: Paul Hastings LLP (Naveen Modi, Yar R. Chaikovsky, Michael C. Hendershot, David T. Okano) — all four also moved pro hac vice (granted Paper 28, 2017-02-13). Petitioner's expert: Dr. Darran Cairns (Ex. 1002). Patent Owner's expert: Darrin J. Young, Ph.D. (Ex. 2001).

• Petition grounds (10 grounds, all 26 claims challenged):

  • Instituted (claims 16–26):
    1. Claims 16–19, 23, 26 — § 102(b) anticipation by Lo (U.S. Pat. Pub. 2006/0264756 to Lo et al., Ex. 1003)
    2. Claims 20–22 — § 103(a) obvious over Lo + Huang
    3. Claim 24 — § 103(a) obvious over Lo + Handbook of Thermoplastic Elastomers
    4. Claim 25 — § 103(a) obvious over Lo + Toyoda
  • Not instituted (claims 1–15), all § 103(a) over Anderson (U.S. Pat. Pub. 2009/0047797, Ex. 1004) + Downey, with secondary references: claims 1, 6, 15 (Ground 5); claims 2, 3, 5 + Huang (Ground 6); claims 4, 7 + Handbook (Ground 7); claims 8, 9 + Toyoda (Ground 8); claims 10–12 + Azuma (Ground 9); claims 13, 14 + Brennan (Ground 10).

• Institution decision: Partially instituted — Decision on Institution, Paper 14 (institution date reported as 2016-08-16 in third-party docket data; scheduling order Paper 15 followed on 2016-08-30). The Board instituted on claims 16–26 and denied institution on claims 1–15, rejecting Fitbit's Anderson-based showing. Fitbit filed a Request for Rehearing on 2016-08-30 (Paper 16), arguing the Board "overlooked" Anderson's Figure 7h, overlooked ¶ 0044 describing an outer shell "overlying filler material 44," and overlooked Dr. Cairns's testimony, and asking the Board to "institute trial on claims 1-15." Rehearing was denied (Paper 18, 2016-10-31). Patent Owner's Preliminary Response (Paper 10, filed 2016-05-18) had argued, inter alia, that Lo's outer molding (1490) "only covers at most one side of its alleged inner molding (1474)" and therefore does not cover "all or substantially all."

• Claim construction fight (worth knowing): the dispute turned on "covers all or substantially all." The Board's preliminary construction (and Petitioner's) was that it "encompasses on top of"; Patent Owner argued it requires "complete coverage, enclosing or encasing" (Institution Decision at 10; PO Resp. 5–16). This constructional axis is what split the two claim families: it defeated institution on Anderson-based claim 1, and it did not save Lo-based claim 16.

• Final Written Decision (if issued): Yes — issued 2017-08-15 (Paper 37), within the § 316(a)(11) one-year deadline from the 2016-08-16 institution date. Disposition at claim level, quoting the panel:

  "we determine that Fitbit has proven, by a preponderance of the evidence, that claims 16-26 of the '811 patent are unpatentable."

  • Canceled: independent claim 16 and every claim depending from it — 17, 18, 19, 20, 21, 22, 23, 24, 25, 26 (all eleven instituted claims were held unpatentable).
  • Held patentable / sustained: none of the instituted claims. The FWD did not reach claims 1–15; those claims were never instituted and were therefore not adjudicated on the merits. Do not let anyone tell you the FWD "confirmed" claims 1–15 — it did no such thing.
  • Procedural record: Patent Owner Response (Paper 21), Petitioner Reply (Paper 29), no observations on cross-examination and no motions to exclude; oral hearing held 2017-05-11 (transcript Paper 36, docketed 2017-07-05; hearing order Paper 33, 2017-04-24).

• Settlement / termination: None. This case ran to a merits FWD. (There is a Notice of Refund, Paper 23, 2016-12-21, but no adverse judgment or settlement termination.)

• Appeal: Not verified in this session — treat as an open question. The patent's structured litigation record lists three CAFC dockets — 16-2175, 16-2187 (both 2016 filings) and 17-1381 — plus an International Trade Commission investigation, 337-TA-963. Because the FWD did not issue until 2017-08-15, an appeal of the IPR would ordinarily have been docketed in late 2017 (an 18-xxxx docket), so on timing grounds 16-2175/16-2187 (and probably 17-1381) are more consistent with the parallel Jawbone–Fitbit ITC/district-court litigation (Fitbit, Inc. v. AliphCom/Jawbone/BodyMedia, N.D. Cal. No. 15-cv-04073-EJD) than with this IPR. I could not confirm a CAFC appeal of the FWD, and I will not assert one.

• Defensive value: Claims 16–26 are dead — any infringement theory built on claim 16 or its dependents (17–26) is not merely weak, it is a meritless claim chart, and pressing it invites Rule 11 exposure. For claims 1–15 the FWD is not a silver bullet, but it is a gift: you inherit a full adversarial record — the Anderson/Downey/Reissue-reference mapping briefed by Paul Hastings and Dr. Cairns, and the Board's reasoning that Anderson's filler 44 "reside[s] in the gaps and/or air pockets" rather than covering all or substantially all — plus the fact that no merits tribunal has ever validated claims 1–15 against that art.

• Sources: FWD PDF — https://www.docketalarm.com/cases/PTAB/IPR2016-00607/Inter_Partes_Review_of_U.S._Pat._8529811/docs/08-15-2017-Board/Final_Decision-37-Final_Written_Decision.pdf ; Petition — https://www.docketalarm.com/cases/PTAB/IPR2016-00607/Inter_Partes_Review_of_U.S._Pat._8529811/docs/02-10-2016-Petitioner/Petition-2-Petition_for_Inter_Partes_Review_of_US_Patent_No_8,529,811.pdf ; Petitioner demonstratives — https://www.docketalarm.com/cases/PTAB/IPR2016-00607/Inter_Partes_Review_of_U.S._Pat._8529811/docs/05-08-2017-Petitioner/Other-34-Petitioners_Demonstratives.pdf ; docket summary (Patexia) — https://services.patexia.com/lawsuits/Fitbit-Inc-v-AliphCom-et-al-id-67026 ; PTAB E2E portal — https://ptacts.uspto.gov/ptab/ ; patent record — https://patents.google.com/patent/US8529811/en

Strategic summary

Claim status on US 8,529,811. The '811 patent has two independent claims: claim 1 (selectively applying a covering → first inner molding → second inner molding → outer molding) and claim 16 (selectively applying a protective material → one or more inner moldings having a protective property → outer molding). The IPR killed the entire claim-16 line: claims 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 and 26 are canceled as unpatentable. The claim-1 line — claims 1 through 15 — is UNTESTED: Fitbit challenged them, the Board refused to institute (Paper 14, denial of institution as to claims 1–15, rehearing denied 2016-10-31), and there has been no merits adjudication of those claims at the PTAB. That matters enormously for the practical posture: an assertion letter citing claim 16 (or the anti-bacterial / oleophobic / hydrophobic / UV / waterproof / pattern features of claims 2–7, which all depend from claim 1 — note claims 2–7 depend from claim 1, not claim 16) is in very different shape depending on which independent claim is pleaded. Plead claim 16 and you are pleading a canceled claim. Plead claim 1 or one of claims 2–15 and the FWD does not dispose of you.

Estoppel landscape. § 315(e)(2) estoppel binds Fitbit, Inc. and its privies on any ground raised or that reasonably could have been raised in IPR2016-00607 — that includes all ten petition grounds, including the Anderson-based Grounds 5–10 on claims 1–15 that the Board declined to institute but which were squarely raised in the petition. Fitbit therefore cannot re-litigate the Anderson/Downey/Azuma/Brennan/Huang/Handbook/Toyoda combinations in district court against claims 1–15. For anyone who is not Fitbit or its privy, § 315(e)(2) does not apply at all — you can file your own IPR against claims 1–15 (subject to the § 315(b) one-year bar running from service of a complaint on you), and you can run your own invalidity case in district court. Note also that IPR estoppel is claim-scoped in practice: because claims 1–15 were never instituted, there is no FWD estoppel attaching to any ground directed at them for third parties, and even for Fitbit the estoppel is a district-court defense tool for you, not a bar to your own petition. One caveat: you cannot obtain a PTAB validity ruling on claims 16–26 — they are already canceled, and the Board will not institute on claims that no longer exist. Conversely, Patent Owner is claim-precluded from reviving claims 16–26 in any later forum.

Pattern signals. (1) One IPR only — a Docket Alarm search on patent:(8529811) returns this single PTAB docket, and the patent page lists no other AIA trial; there is no second petitioner, no PGR, no CBM, and no follow-on IPR by a defensive aggregator. (2) The petitioner was Fitbit, a direct competitor, not Unified Patents — the "Unified Patents PTAB Data" label on the patent page is a data-source attribution in Google Patents, not an indication that Unified Patents filed or funded this challenge. Do not represent to a court or client that a defensive aggregator is in the chain. (3) The patent owner did not win anything here — Jawbone/AliphCom lost all eleven instituted claims; the only thing it preserved was claims 1–15 by defeating institution, which is a procedural win, not a merits vindication. (4) Ownership has fragmented — the patent moved AliphCom → assignment of security interests (DBD Funding, Wells Fargo, Silver Lake) → releases → JB IP Acquisition LLC (2019-07-19) → J Fitness LLC (UCC financing statements, 2019-07-22). That is a monetization-failure chain, not an active licensing program, and it is consistent with the "Expired - Fee Related" status. (5) Litigation context, for completeness: the ITC investigation 337-TA-963 and the three CAFC dockets (16-2175, 16-2187, 17-1381) on the patent record arise from the Jawbone–Fitbit war (including Fitbit, Inc. v. AliphCom/Jawbone/BodyMedia, N.D. Cal. No. 15-cv-04073-EJD), not from any AIA trial — I did not verify their dispositions and you should pull them if you need them.

Recommended next steps

1. If you are a defendant and the assertion cites claims 16–26: quote the disposition. The Board wrote: "we determine that Fitbit has proven, by a preponderance of the evidence, that claims 16-26 of the '811 patent are unpatentable" (IPR2016-00607, Paper 37, 2017-08-15 — https://www.docketalarm.com/cases/PTAB/IPR2016-00607/Inter_Partes_Review_of_U.S._Pat._8529811/docs/08-15-2017-Board/Final_Decision-37-Final_Written_Decision.pdf). Ask the plaintiff to withdraw those claims in writing; if they persist, seek fees under 35 U.S.C. § 285 and consider a Rule 11 safe-harbor letter. Also demand the infringement contentions be stricken to the extent they map to canceled claims.
2. If the assertion cites claims 1–15: your PTAB doors are open. File your own IPR (mind the § 315(b) one-year clock from service of the complaint) using the Anderson-based grounds the Board never reached — Grounds 5–10 from Fitbit's petition are a ready-made template, and you are not bound by Fitbit's failure at institution because that denial has no preclusive effect. Expect the Patent Owner to argue the same "covers all or substantially all" construction it won with at institution ("complete coverage, enclosing or encasing") — pre-empt it by briefing that construction head-on, since it is the single dispositive limitation that split this patent in two.
3. No active PTAB proceedings exist, so there are no institution deadlines, no oral-hearing dates, and no § 316(a)(11) FWD due dates to track. If you want a trial timetable, it is the one you create by filing.
4. Check the fee status before you spend money. The patent record shows "Expired - Fee Related" with an anticipated expiration of 2031-06-10 — i.e., the maintenance-fee lapse, not the term, is what ended enforceability. If confirmed at the USPTO Patent Center (https://patentcenter.uspto.gov/), a lapsed patent supports no infringement action for post-lapse conduct and materially strengthens a § 285 fee motion. Verify this independently before relying on it; Google Patents' legal-status field is expressly noted there as an assumption.
5. Pull the FWD in full and the papers I could not read (the Institution Decision, Paper 14; the rehearing denial, Paper 18; the hearing transcript, Paper 36) from PTAB E2E, and confirm whether any CAFC appeal of the FWD was filed and how the three listed CAFC dockets resolved — I flagged that as unverified rather than guessing.

I'll research the assignment records for this patent before drafting. Let me run several targeted searches.

Let me dig for the specific reel/frame records and NPE-directory entries.

Excellent — the RPX and IPWatchdog sources are revealing the chain. Let me pin down the specific entities and any reel/frame data.

Ownership & Assignment Analysis — US 8,529,811 B2

Data-availability caveat up front (important). I was able to reach the USPTO-derived legal-event records mirrored on Google Patents for this patent, and derivative reporting from RPX and IPWatchdog on the AliphCom/Jawbone liquidation. I was not able to open the Assignment Center / EPAS record-and-reel detail pages for US 8,529,811 with the tools available in this session. Consequently:

• Recordation dates, conveyance types, assignors and assignees below are sourced and cited.
• Reel/frame numbers and "correspondent of record" fields are marked not retrieved wherever I do not have them. I will not invent them. Two reel/frame numbers do appear inside this patent's own legal-event text and are reported as such.
• Where the Assignment Center search will resolve the gap, I give the exact query URL.

Inventors

Basis for employer call: the application was filed by AliphCom on 2012-03-22 and all four inventors executed an "ASSIGNMENT OF ASSIGNORS INTEREST" to ALIPHCOM recorded 2013-09-21 (Google Patents legal events). Amazon's 2022 §1404(a) motion in Jawbone Innovations, LLC v. Amazon.com, Inc. (E.D. Tex. 2:21-cv-00435) independently confirms that "the patents originated [at] a company called AliphCom … headquartered in the Northern District of California," which is why the inventors and prosecuting attorneys are there.

Unusual-pattern check:

• No evidence of all inventors departing within 12 months of filing. I found no departure data for Drysdale, Fullam, Orvis or Levinson, and I will not infer one. Mark: unclear / not evidenced.
• One real oddity worth noting: the inventor→company assignment was not recorded until 2013-09-21, roughly 27 months after the 2011-06-10 priority date and 11 days after issuance (2013-09-10). Late recordation of employee assignments is common in venture-backed startups and is not by itself an NPE signal — but it means the patent's face shows a period in which record title and equitable title were out of sync.
• Do not conflate these inventors with the six inventors referenced in the Amazon motion — that passage concerns the nine audio/microphone patents in the 2021 Jawbone Innovations campaign, not the '811 wearable-overmolding patent.

Original assignee

Entity on the issued patent: AliphCom (d/b/a Jawbone), a California corporation, 99 Rhode Island St., 3rd Floor, San Francisco, CA 94103.

• Did they ship a product embodying the claims? Yes. The '811 specification is directed to overmolding a "data-capable strapband," and AliphCom commercialized exactly that: the Jawbone UP wristband (announced 2011), followed by UP24, UP Move, UP2, UP3 and UP4. The disclosed overmolded sensor/electronics band is the UP product line. AliphCom also sold the JAMBOX/BIG JAMBOX/MINI JAMBOX speakers and Jawbone/Icon Bluetooth headsets, but the '811 subject matter maps to the UP wearables.
• Primary line of business: consumer electronics — Bluetooth headsets, portable wireless speakers, then wearable activity/lifestyle trackers. Founded 1999 as Aliph, Inc.; the wearable pivot began 2011. ~19% of the retail fitness-tracker market in 2013 (behind Fitbit).
• Current status: Liquidated. On 2017-06-19 AliphCom made a General Assignment for the Benefit of Creditors (California's out-of-court insolvency mechanism, not a Chapter 7/11) to AliphCom (assignment for the benefit of creditors), LLC, P.O. Box 391600, Mountain View, CA 94039, Manager: Michael A. Maidy. Proof-of-claim bar date: 2017-12-19. Jawbone is generally reported as dissolved July 2017. CNBC's reporting put the patent portfolio value at $12–15 million against a company once valued at ~$3 billion.
• Public-company cross-reference: none available. AliphCom/Jawbone was private (Sequoia, Andreessen Horowitz, Khosla, et al.). There is no 10-K/8-K to check. The security agreements on this patent (DBD Credit Funding / Fortress → Wells Fargo → Silver Lake Waterman → BlackRock) are the functional substitute for SEC disclosure and are the reason the chain of title is lien-heavy.
• Prior assertion posture (pre-liquidation): AliphCom and its subsidiary BodyMedia sued Fitbit itself (N.D. Cal. 3:15-cv-02579, filed 2015-06-10) and filed ITC Inv. No. 337-TA-963. That was an operating-company-vs-operating-company fight over U.S. 8,446,275, 8,398,546 and 8,073,707 — the '811 was not among the asserted patents; it surfaced instead as the target of IPR2016-00607 (Fitbit v. AliphCom), Final Written Decision 2017-08-15.

Assignment timeline

Source note: entries below are the USPTO-derived legal events shown on Google Patents (https://patents.google.com/patent/US8529811/en). Google Patents dates are recordation dates unless otherwise stated. Reel/frame and Correspondent were not retrievable in this session — they must be read off the Assignment Center detail page. The two reel/frame numbers that do appear — 036500/0173 and 035531/0554 — appear only because a corrective-assignment caption recited them.

1. 2013-08-08 / recorded 2013-08-08 — Reel not retrieved

   • Conveyance: Security Agreement
   • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition LLC
   • Assignee: DBD Credit Funding LLC, as Administrative Agent
   • Correspondent: not retrieved
   • Context: Securitization — venture-debt collateral package; DBD Credit Funding is a Fortress Investment Group entity.

2. executed (n.d.) / recorded 2013-09-21 — Reel not retrieved

   • Conveyance: Assignment of Assignors' Interest
   • Assignor: Drysdale, Richard Lee; Fullam, Scott; Orvis, Skip Thomas; Levinson, Nora Elam
   • Assignee: AliphCom
   • Correspondent: not retrieved
   • Context: Initial inventor→company assignment (recorded 11 days post-issuance).

3. 2013-12-04 — Reel not retrieved

   • Conveyance: Patent Security Agreement
   • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition LLC
   • Assignee: Wells Fargo Bank, National Association, as Agent
   • Correspondent: not retrieved
   • Context: Securitization — second lien layer stacked on the DBD facility.

4. 2014-12-03 — Reel not retrieved

   • Conveyance: Notice of Substitution of Administrative Agent in Patents
   • Assignor: DBD Credit Funding LLC, as resigning agent
   • Assignee: Silver Lake Waterman Fund, L.P., as successor agent
   • Correspondent: not retrieved
   • Context: Securitization — agent substitution only; no change in beneficial ownership.

5. 2015-04-28 — Reel not retrieved

   • Conveyance: Security Interest
   • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition LLC; Project Paris Acquisition LLC
   • Assignee: BlackRock Advisors, LLC
   • Correspondent: not retrieved
   • Context: Securitization — refinancing; BlackRock becomes the senior secured party.

6. 2015-04-28 — Reel not retrieved

   • Conveyance: Release by Secured Party
   • Assignor: Wells Fargo Bank, N.A., as Agent
   • Assignee: AliphCom; Aliph, Inc.; BodyMedia, Inc.; MacGyver Acquisition LLC; Project Paris Acquisition LLC
   • Correspondent: not retrieved
   • Context: Securitization housekeeping — release of the Wells Fargo lien upon refinancing.

7. 2015-04-28 — Reel not retrieved

   • Conveyance: Release by Secured Party
   • Assignor: Silver Lake Waterman Fund, L.P., as Administrative Agent
   • Assignee: same obligor group as #6
   • Correspondent: not retrieved
   • Context: Securitization housekeeping — release of the Silver Lake lien upon refinancing.

8. 2015-08-27 — Reel not retrieved

   • Conveyance: Security Interest
   • Assignor: obligor group as in #5
   • Assignee: BlackRock Advisors, LLC
   • Correspondent: not retrieved
   • Context: Securitization — second BlackRock grant four months later.

9. 2017-01-26 — Reel 036500/0173 (as recited in the corrective caption)

   • Conveyance: Corrective Assignment — correcting application no. 13/870,843, previously recorded at reel 036500 / frame 0173
   • Assignor: Aliph, Inc.; AliphCom; BodyMedia, Inc.; MacGyver Acquisition LLC; Project Paris Acquisition LLC
   • Assignee: BlackRock Advisors, LLC
   • Correspondent: not retrieved
   • Context: Securitization correction — caption error fix, not a title transfer.

10. 2017-11-02 — Reel 035531/0554 (as recited in the corrective caption)

    • Conveyance: Corrective Assignment confirming release of security interest — correcting app. no. 13/982,956, previously recorded at reel 035531 / frame 0554
    • Assignor: Silver Lake Waterman Fund, L.P., as Administrative Agent
    • Assignee: BodyMedia, Inc.; Aliph, Inc.; AliphCom; MacGyver Acquisition LLC; Project Paris Acquisition LLC
    • Correspondent: not retrieved
    • Context: Securitization correction — papering the earlier release.

11. 2019-07-19 — Reel not retrieved

    • Conveyance: Assignment of Assignors' Interest
    • Assignor: AliphCom, LLC; BodyMedia, Inc.
    • Assignee: JB IP Acquisition LLC
    • Correspondent: not retrieved
    • Context: Post-liquidation asset sale / transfer-to-holder — this is the operative transfer of title out of the Jawbone estate. Note the assignor is "AliphCom, LLC" (with comma), not the original "AliphCom" corporation — this most plausibly resolves to the ABC assignee vehicle, but the Assignment Center record must be read to confirm.

12. 2019-07-22 — Reel not retrieved

    • Conveyance: UCC Financing Statement
    • Assignor: JB IP Acquisition, LLC
    • Assignee: J Fitness LLC
    • Correspondent: not retrieved
    • Context: Securitization / lien — the new owner pledges the portfolio to its financier three days after acquiring it.

13. 2019-07-22 — Reel not retrieved

    • Conveyance: UCC Financing Statement
    • Assignor: Jawbone Health Hub, Inc.
    • Assignee: J Fitness LLC
    • Correspondent: not retrieved
    • Context: Securitization / lien — shows the "J" entities and Jawbone Health Hub are being financed through a common secured party.

14. 2019-07-22 — Reel not retrieved

    • Conveyance: Security Interest
    • Assignor: JB IP Acquisition, LLC
    • Assignee: J Fitness LLC
    • Correspondent: not retrieved
    • Context: Securitization / lien — the assignment-backed counterpart to item 12.

15. 2019-08-08 — Reel not retrieved

    • Conveyance: Release by Secured Party
    • Assignor: BlackRock Advisors, LLC
    • Assignee: AliphCom LLC
    • Correspondent: not retrieved
    • Context: Securitization cleanup — clearing the last 2015 BlackRock lien.

16. 2019-08-15 — Reel not retrieved

    • Conveyance: Release by Secured Party
    • Assignor: Jawbone Health Hub, Inc.; JB IP Acquisition, LLC
    • Assignee: J Fitness LLC
    • Correspondent: not retrieved
    • Context: Securitization cleanup — a release running to J Fitness LLC, i.e. internal to the J-entity group.

Reel/frame and correspondent status: for 14 of the 16 entries above I hold dates, conveyance types and parties but not reel/frame or correspondent. The only reel/frame data points I can attribute are 036500/0173 (BlackRock security grant) and 035531/0554 (Silver Lake Waterman release), both recited inside this patent's own legal-event captions. I will not fabricate the rest.

Correspondent data points I can document — but from adjacent records, not this patent's assignment reel:

• Michael A. Maidy, Manager, AliphCom (assignment for the benefit of creditors), LLC — signature block on the 2017-06-19 ABC notice (http://www.proofofclaims.com/AliphCom/documents/AliphCom-POC_Notice.pdf).
• Luke Conticello, JAWB Acquisition LLC, 321 West 44th Street, New York, NY 10036, with CPA Global Limited (Liberation House, Castle Street, St Helier, Jersey JE1 8BL, Channel Islands) acting on the 2019 small-entity filing in the related '091 prosecution history (Ex. 1002, IPR2022-00649).
• Daniel Setton, identified by RPX as Manager of JAWB Acquisition LLC and a manager of Lionel Capital ("distressed assets in need of a turnaround"; lists "Aliph Brands" as an investment).

These are address/agent data points for the sibling entity chain, not correspondents of record on the '811 assignment reels. Treat them as leads to verify, not findings.

⚠️ Contradiction to flag: the pre-existing summary in this analysis (and Google Patents) names the terminal owner as JB IP Acquisition LLC (2019-07-19), secured by J Fitness LLC. RPX's coverage of the parallel Jawbone assertion chain describes a different set of names: JAWB Acquisition LLC (NJ, formed July 2017, manager Daniel Setton) → JI Audio Holdings LLC (TX, formed 2021-05-07) → Jawbone Innovations LLC (75 patents assigned 2021-05-18, asserting acoustic/microphone patents against Samsung, Apple and Google). These are not the same entities on their face. My working read — which I cannot confirm — is that the audio/microphone patents went down the JAWB → JI Audio Holdings → Jawbone Innovations path while the wearables/health patents went down the JB IP Acquisition → J Fitness path. Confirm before relying on either.

Timeline diagram

timeline
    title Ownership of US 8529811
    2011 : Priority date Jun 10
    2012 : Application filed by AliphCom
    2013 : Patent issued Sep 10
         : Inventors assign to AliphCom
         : DBD Credit Funding security
         : Wells Fargo security
    2014 : Silver Lake Waterman becomes agent
    2015 : BlackRock security interest
         : Wells Fargo lien released
         : Silver Lake lien released
    2017 : AliphCom insolvent general assignment
         : BlackRock corrective filings
    2019 : Assigned to JB IP Acquisition LLC
         : J Fitness LLC liens recorded
         : BlackRock release recorded

NPE / troll-pattern signals

1. Shell-entity transfer — PRESENT (partially evidenced).
The patent moved from the operating assignee group (AliphCom/BodyMedia) to JB IP Acquisition LLC by the 2019-07-19 assignment. The name suffix "IP Acquisition" and the absence of any product business are consistent with a holding vehicle, and the LLC immediately pledged the assets to J Fitness LLC (2019-07-22). Caveat I will not paper over: I could not verify JB IP Acquisition LLC's registered address, membership, or product activity, and Google Patents itself labels its assignee data as possibly inaccurate. Per your instruction, naming alone is not a finding — so this signal is present on the transfer facts, incompletely evidenced on the shell-entity facts.

2. Known asserter in the chain — NOT PRESENT for this asset.
No assignee on the '811 chain matches Acacia, Marathon, Intellectual Ventures, IPNav, Wi-LAN, Mosaid/Conversant, Vringo, Pendrell, Innovatio, MPHJ, Lumen View, Round Rock, Document Generation Corp, or any Spangenberg entity. However, note the sibling chain: RPX and IPWatchdog both describe Jawbone Innovations, LLC as a repeat plaintiff asserting eight acoustic/microphone patents against Samsung (2021-05-27), Apple (W.D. Tex. 6:21-cv-00984, 2021-09-23) and Google (6:21-cv-00985, 2021-09-23). I found no pleading asserting U.S. 8,529,811; the only adversarial proceeding naming it is the Fitbit IPR.

3. Repeat correspondent across the chain — UNCLEAR (not retrieved).
I cannot report correspondents of record for the '811 reels. The recurrence test can only be run once the Assignment Center detail pages are pulled. Partial cross-record leads: Daniel Setton (JAWB Acquisition LLC / Lionel Capital) signs as manager on the 2017-era transfers in the sibling chain; Luke Conticello appears with CPA Global on the 2019 filing; Michael A. Maidy managed the ABC vehicle. None of these is confirmed as a correspondent on this patent's reels.

4. Cascading transfers — PRESENT.
Sixteen recorded events in six years, including a security-lien stack (DBD 2013-08-08 → Wells Fargo 2013-12-04 → Silver Lake substitution 2014-12-03 → BlackRock 2015-04-28 → BlackRock 2015-08-27 → corrective 2017-01-26 → release corrective 2017-11-02), then three J Fitness filings at 2019-07-22 just three days after the title transfer. The genuine ownership transfers, however, are fewer than the recording count suggests: inventor→AliphCom (2013), estate→JB IP Acquisition LLC (2019), plus the 2017 ABC that underlies it. So: cascade of recordings present; cascade of consecutive LLC title hops only narrowly present.

5. Pre-litigation transfer — NOT PRESENT.
JB IP Acquisition LLC's acquisition (2019-07-19) predates the 2021 Jawbone Innovations campaign by roughly two years, and I found no infringement suit naming U.S. 8,529,811 at all. The only pre-2019 assertions of the Jawbone portfolio were by AliphCom itself (Fitbit, 2015) — the operating company, not an assignee-NPE. Mark: not present.

6. Bankruptcy fire-sale — PRESENT (functionally), with a precision caveat.
AliphCom did not file Chapter 7 or 11. It made a General Assignment for the Benefit of Creditors on 2017-06-19 to AliphCom (assignment for the benefit of creditors), LLC (Manager Michael A. Maidy), with a 2017-12-19 proof-of-claim bar. This is California's non-judicial insolvency liquidation and is the functional equivalent of a fire-sale. Corporate assets were transferred "to Assignee for liquidation." CNBC valued the portfolio at $12–15M against a former ~$3B valuation.

7. Privateering — NOT PRESENT.
Classic privateering requires an operating company transferring to an NPE that asserts on its behalf. Here the operating company ceased to exist in 2017; the later campaign was run by a fund-backed entity (Lionel Capital / JAWB Acquisition) after the operating company was gone, and it does not name this patent.

8. Defensive aggregator (anti-NPE) — NOT PRESENT.
The chain terminates at JB IP Acquisition LLC with a lien held by J Fitness LLC. It does not terminate at RPX, AST, LOT Network, Unified Patents, or OIN. The patent has not been neutralized. Its legal status is Expired – Fee Related, with anticipated expiration 2031-06-10 — i.e. it was allowed to lapse for non-payment of maintenance fees, which is its own telling signal about perceived value.

Verdict

NPE — moderate confidence

Justification: the patent demonstrably left operating-company hands when AliphCom, LLC and BodyMedia, Inc. assigned it to JB IP Acquisition LLC on 2019-07-19, and the acquirer pledged the assets to J Fitness LLC three days later (2019-07-22) — a named acquisition/holding LLC that I cannot tie to any product business, layered on top of a documented insolvency liquidation (AliphCom General Assignment for the Benefit of Creditors, 2017-06-19, Manager Michael A. Maidy). That is one strong signal (fire-sale) plus substantial supporting structure (acquisition-vehicle transfer, lien cascade, and a sibling chain terminating at admitted high-frequency plaintiff Jawbone Innovations, LLC). I stop short of high confidence because I could not retrieve the reel/frame or correspondent records to confirm the shell-entity facts, could not confirm any assertion of this patent by any post-2019 owner, and cannot rule out an affiliation between the "J" entities and the Jawbone Health Hub operating business.

Verify at: https://assignmentcenter.uspto.gov/ and https://assignment.uspto.gov/patent/index.html — search 8529811, then read the Reel/Frame and Correspondent columns for each of the 16 entries above, with particular attention to (a) the 2019-07-19 assignee address and correspondent, and (b) whether a 2017 ABC assignment naming this patent was recorded and merely omitted from the Google Patents event feed.

I'll research this patent number and its citation record. Let me run several targeted searches.

I have a partial reference list. Let me retrieve the complete "References Cited" from the front page and check for cited-by and non-patent literature.

Prior-Art Analysis — US Patent No. 8,529,811 B2

Note on identification: I searched the literal number 8,529,811. All results below correspond to US 8,529,811 B2, "Component protective overmolding using protective external coatings" (AliphCom; appl. 13/427,839; filed 2012‑03‑22; issued 2013‑09‑10; priority 2011‑06‑10). No similar-number substitutes are included.

Source for the citation record: the issued patent's own front page (56) "References Cited" as reproduced in the patent image file:
https://patentimages.storage.googleapis.com/bf/7c/ba/a971a7ee13ada3/US8529811.pdf
and the Google Patents bibliographic/classification page: https://patents.google.com/patent/US8529811/en

Important caveats up front (please read before relying on the tables):

1. The front-page reference list I retrieved is truncated in the available OCR (the U.S. list runs off at "7,993,2…"). The full list, including any cited U.S. patent-application publications and the Non-Patent Literature (NPL) citations, and the examiner's PTO‑892 form, should be confirmed in USPTO Patent Center / the file wrapper for 13/427,839. I could not retrieve those items and will not invent them.
2. Titles/assignees for several references could only be inferred from their patent numbers, dates, and classifications. Where I am not confident of a title, I say so rather than assert it.
3. Asterisks (*) appear in the OCR next to certain entries (e.g., 6,254,815 B1 and 7,060,216 B2). On USPTO front pages an asterisk conventionally marks a reference cited by the examiner (as opposed to applicant‑cited); I report the asterisks as printed and flag their likely meaning without over‑claiming.

1. The references cited on the face of US 8,529,811

1A. Molding / encapsulation references — the most technically relevant to the claims

These are the only cited references whose subject matter is shaping/molding material around electronic components, i.e., the field of the claimed method.

1B. Wearable physiological‑monitoring / sensor‑device references (background art)

This is the large majority of the cited U.S. patents. They are directed to wearable sensing and data‑capture devices (assignee cluster: BodyMedia‑type armband monitoring, and Nike‑type activity/locomotion patents). They supply the "wearable device," "sensor," and "framework/substrate" context but do not disclose the claimed selective‑coat‑then‑multi‑mold sequence.

Design patents (ornamental, no method disclosure):

• US D439,981 S — Kasabach et al. — 4/2001
• US D451,604 S — Kasabach et al. — 12/2001
• US D631,552 S — Kasabach et al. — 1/2011
• US D632,396 S — Kasabach et al. — 2/2011
• "6,060,971 S" — Sica et al. — 7/2002. ⚠️ Anomaly: the OCR prints a utility‑format number where the "S" suffix indicates a design patent (i.e., a D‑number). Per your literal‑interpretation rule I have not corrected it; treat this entry as needing verification in the file wrapper.

2. What the cited art does — and does not — anticipate under 35 U.S.C. § 102

Applying the rule that a reference anticipates only if it discloses every limitation:

Claim 1 requires, in order: (a) selectively applying a covering over element(s) on a wearable‑device framework including at least a sensor; (b) selectively forming a first inner molding over the covering + elements + framework; (c) selectively forming a second inner molding over the first; and (d) selectively forming an outer molding over the second, the outer molding configured to contact the user.

Claim 16 requires: (a) selectively applying at least one protective material over element(s) on a wearable‑device framework including at least a sensor; (b) forming one or more inner moldings over a subset or all of the framework/protective material/elements after the selective applying, at least one inner molding having a protective property; and (c) forming an outer molding covering all/substantially all of the inner molding(s), configured to contact the user.

Conclusions:

• No cited reference, on its own, anticipates claim 1 or claim 16. The wearable‑monitoring cluster (Stivoric/Teller/Kahn/Farrington/Jones) discloses wearable bands with sensors and housings, but none of them discloses the recited selective‑application step followed by successive inner/outer molding — the core of both independent claims. They are § 102 art only with respect to isolated recitations (the "wearable device"/"sensor"/"framework" environment), not the claimed method as a whole.
• The two encapsulation references (US 6,254,815 B1 and US 7,030,781 B2) are the closest cited art to the molding limitations. Each appears directed at encapsulating/overmolding an electrical component (they are the only cited references classified in molding sub‑classes 264/135 and 264/272.15, and one or both carry the examiner‑citation asterisk). Read alone, each could arguably reach the molding limitations of claims 1 (steps b–d), 16 (step b) and claim 23 ("protect the elements from damage occurring during the forming of the inner molding(s)"). But neither appears to disclose (i) a wearable device, (ii) an element set including a sensor, or (iii) an outer molding configured to be positioned in contact with the user — all of which are required by both independent claims. So they do not anticipate claims 1 or 16 either; their relevance is as § 103 combination art against the molding sequence.
• Dependent claims are where the cited art bites hardest, but still indirectly. E.g., claims 10–14 (framework of synthetic fiber / carbon fiber / filaments / TPE / polypropylene) and claims 15 and 26 (a curable coating) overlap with conventional overmolding/coating practice generally; the cited molding references (and NPL such as GLS/PolyOne overmolding guides, which appear in this family's search reports) are the type of art that would be used against such dependent features — but only in combination, and only once the independent‑claim method is separately taught. Note: I could not confirm that any GLS/PolyOne "Overmolding Guide" NPL was cited on this patent's face; it is cited in a related family, so treat it as a lead to check, not a confirmed citation.

Net assessment: the references on the face of 8,529,811 are predominantly cited as background (wearable sensor/data‑capture art), with only two genuinely molding‑oriented references (Cheprak '815 and Schuurmans '781) that touch the claimed process. On the record available to me, no single cited reference anticipates claims 1 or 16 under § 102; their realistic role is § 103 combination material against the molding sequence and the material‑property dependent claims.

3. Items that are not prior art (flagged to prevent miscounting)

• Family/priority applications of the same inventors and common owner — these are not § 102 prior art against 8,529,811 (same effective priority date of 2011‑06‑10; common ownership):
  • US 2012/0313272 A1 (Ser. 13/158,372, filed 2011‑06‑10)
  • US 2012/0313296 A1 (Ser. 13/158,416, filed 2011‑06‑11)
  • US 2012/0315382 A1 (Ser. 13/135,728, filed 2011‑07‑12 — the immediate parent)
  • US 2012/0315379 A1 (the publication of the application at issue)
• Forward citations ("Cited By") — not prior art; they post‑date 8,529,811:
  • US 2015/0029644 A1 — Alcazar — 2015‑01‑29 (RF‑transparent woven material for a wearable device)
  • WO 2016/187716 A1 — GestureLogic — 2016‑12‑01 (garments with secured articles)
• Sibling international filings of the same family (WO 2012/170108, WO 2012/170107, WO 2012/170362, EP 2 719 266, EP 2 718 863, EP 2 719 265, etc.) — counterparts, not prior art.

4. Recommended next steps to complete the record

1. Pull the PTO‑892 / PTO‑1449 and full (56) list for Ser. 13/427,839 from USPTO Patent Center to recover the truncated entries (beyond "7,993,2…"), any cited U.S. pre‑grant publications, and the NPL citations I could not retrieve.
2. Retrieve the documents themselves for US 6,254,815 (Cheprak), US 7,030,781 (Schuurmans) and CA 2496579 and map each against claims 1, 16 and 23 element‑by‑element — these are the only cited references with real § 102/§ 103 potential on the molding steps.
3. If validity (not prosecution) is the objective, the more probative art will be the grounds in the IPR2016‑00607 (Fitbit v. AliphCom) petition and Final Written Decision. I flagged in the prior section that I could not verify the FWD outcome, and I likewise cannot confirm from my searches that IPR2016‑00607 is directed to this patent as opposed to a sibling — please verify against the PTAB record before citing it: https://portal.unifiedpatents.com/ptab/case/IPR2016-00607

Authoritative URLs used: https://patents.google.com/patent/US8529811/en ; https://patentimages.storage.googleapis.com/bf/7c/ba/a971a7ee13ada3/US8529811.pdf ; https://patents.google.com/patent/US20120315379A1/en

If you can supply the PTO‑892 or the file‑wrapper reference list, I will complete the claim‑by‑claim § 102 mapping for the references I could not fully retrieve.

I'll research the prior-art record before analyzing. Note upfront: the "Prior Art section" in the provided page content contains only the keywords (protective, molding, elements, framework, outer molding) and the prior-art date (2011-06-10) — no reference list. Let me pull the actual prior-art references, especially those at issue in IPR2016-00607.

The IPR record is the key evidentiary anchor. Let me identify the specific references (Lo, Anderson, Downey, Huang, Toyoda) and the patent's own cited art.

Obviousness Analysis — US 8,529,811 B2 under 35 U.S.C. § 103

0. Threshold note on the "Prior Art section of this page" (read this first)

I have to flag a sourcing problem before the analysis, because it affects what can honestly be asserted.

The page content supplied for US 8,529,811 contains a "Prior art keywords" field (protective; molding; elements; framework; outer molding) and a "Prior art date" of 2011‑06‑10 — but no prior-art reference list. Google Patents' "Prior Art" heading on that page is a keyword-mapping widget, not a citation table. So the instruction to "use the results from the Prior Art section of this page" cannot be executed literally; there are no references there to combine.

I therefore grounded this analysis in the three prior-art sources that actually exist for this patent and that I could retrieve:

1. The references cited on the face of the patent (the "(56) References Cited" list, from the granted PDF at patentimages.storage.googleapis.com).
2. The prior art actually applied against these claims in IPR2016‑00607 (Fitbit v. AliphCom), which is the only adjudicated §102/§103 record for this patent.
3. Additional art I surfaced in search (identified below).

Contradiction to flag against the previously generated section. The prior summary stated: "I could not independently verify the outcome of the IPR2016‑00607 Final Written Decision (e.g., whether claims were cancelled or upheld)." That caveat is now resolved and should be superseded: the Final Written Decision of August 15, 2017 held that Fitbit proved by a preponderance that claims 16–26 are unpatentable. Source: Docket Alarm FWD PDF, corroborated by Patexia case summary ("Claims Invalidated: 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26").

1. Governing legal framework and critical date

• The patent has a priority date of June 10, 2011 and was filed March 22, 2012 — i.e., pre‑AIA. Pre‑AIA § 103(a) and § 102(a)/(b)/(e) govern. Per the Board and the parties' experts, the relevant time is June 10, 2011. (IPR2016‑00607, Ex. 2001 Young Decl. ¶13: "the relevant timeframe … is June 10, 2011.")
• The obviousness test is Graham v. John Deere (scope/content of art; differences; level of ordinary skill; secondary considerations) applied through KSR Int'l v. Teleflex (550 U.S. 398 (2007)) — a motivation to combine may come from the references themselves, from the nature of the problem, or from the "finite number of identified, predictable solutions"; the results of such a combination need not be guaranteed, only predictable. The Board recited exactly this framework in the companion IPR on the same family (IPR2016‑00714 FWD at § 2, PDF).
• Level of ordinary skill (POSITA): an artisan with a degree in mechanical/electrical engineering or polymer processing plus several years' experience in injection molding and/or wearable sensor packaging — as evidenced by the reference disclosures themselves (Okajima). Both experts (Cairns for Fitbit, ~20 yrs; Young for Jawbone, IEEE Sensors Council) qualify at that level.

2. The prior-art landscape

2.1 Art applied in IPR2016‑00607 (the authoritative §103 record)

The Board instituted trial only as to claims 16–26, on four grounds (FWD; Petitioner's Demonstratives, Paper 34):

The petition also pressed, but the Board declined to institute, grounds 5–10 striking at claims 1–15 through Anderson + Downey, plus secondary references Huang, Handbook of Thermoplastic Elastomers, Toyoda, Azuma, and Brennan (Petition filed Feb. 10, 2016, PDF). Fitbit's Request for Rehearing was denied (Paper 18, Oct. 31, 2016), leaving claims 1–15 unadjudicated.

Caveat (material): I could not extract the full citations (patent numbers/publication dates) for Lo, Anderson, Downey, Huang, Toyoda, Azuma, or Brennan in this session. I can confirm their roles from the IPR papers but not their identities. The analysis below treats them at the role level; anyone relying on this should pull Exhibits 1003–1010 from the IPR docket.

2.2 Art cited on the face of the patent (all § 102(b)/§ 102(e) art by definition of being listed)

From the granted PDF, the "(56) References Cited" list is dominated by wearable body-monitoring patents — Stivoric (7,020,508; 7,060,216; 7,153,262; 7,285,090), Teller (6,605,038; 7,261,690; 7,689,437), Kahn (7,343,260; 7,547,719; 7,647,195/196; 7,653,508; 7,662,056; 7,690,556; 7,705,723; 7,747,735; 7,753,861; 7,788,059), Farrington (7,502,643), Sivovic (6,527,711; 6,595,939), Jones (6,486,801; 6,714,859; 6,904,359; 6,952,645; 7,490,970). Critically, it also contains art directed to encapsulating electronics by molding:

• US 6,254,815 B1 (Cheprak) — classified 264/135 (coating by molding).
• US 7,030,781 B2 (Schuurmans) — classified 264/272.15 (semiconductor device encapsulation by molding).
• CA 2496579 (2004).

These are the applicant's own admissions of what a POSITA knew about molding protective material around sensitive electronics.

2.3 Art surfaced in search (relevant, not in the IPR record)

• DE 102010039329 A1 — "Overmolding method for a sensor device" (Google Patents). Teaches: (i) providing a sensor module completely enclosed by a first medium; (ii) overmolding it with a second medium such that a sealing connection forms between the first and second media. This is a near‑direct read on claim 1's "first inner molding … second inner molding" and on claim 16's "inner molding … outer molding." The stated prior art in its background also confirms two‑step sensor overmolding (elastomer then thermoplastic housing) was known.
• US 2011/0213225 A1 (Abbott Diabetes Care) — filed Aug. 31, 2010; published Sept. 1, 2011 (Justia). Teaches low‑pressure/low‑temperature overmolded circuitry for on‑body electronics, expressly to shield temperature‑sensitive sensor components from molding heat, and expressly contemplates UV‑cured material encapsulation. Available as § 102(e) art as of its Aug. 31, 2010 filing date.
• Co-molding rationale from the patentee's own field: in the parallel Otter line, the co-molding reference Bodkin was cited for the proposition that co-molding can "incorporate different properties, colors, textures, shapes, or other characteristics" (PTAB filing). This is a textbook KSR-style motivation for stacking moldings with different properties.

3. Claim-by-claim § 103 analysis

3.1 Independent claim 16 — strongest obviousness case; already adjudicated

Claim 16 requires only: (a) selective application of protective material over elements on a wearable framework, including a sensor; (b) one or more inner moldings over the framework/material/elements, at least one having a protective property; (c) an outer molding covering the inner molding(s), positioned in contact with the user.

Combination: Lo (primary) + Huang / Handbook of TPE / Toyoda (secondary).

• Lo alone was held to anticipate claim 16. Anticipation is the a fortiori case of obviousness — if a single reference discloses every element, a POSITA would necessarily have arrived at the claim. (The Board's institution decision and FWD are the authority here.)
• For the dependent limitations:
  • Claims 20–22 (hydrophobic / oleophobic / anti‑bacterial inner molding): Lo + Huang, § 103(a). Motivation: the inner molding is the layer in contact with the user's skin through the outer molding, and skin-contact hygiene/water-resistance are recognized design goals for a wrist-worn device; Huang supplies the materials teaching, and the patent's own specification concedes these properties are conventional coating characteristics (see § 3.4).
  • Claim 24 (medical-grade TPE inner molding): Lo + Handbook of Thermoplastic Elastomers. Motivation: selecting a medical-grade grade of TPE for a skin-contacting wearable is a predictable, catalog-type selection among a finite set of known grades — the classic KSR "obvious to try" situation. The specification itself names commercial TPEs (Versaflex 9545‑1, PolyOne) and states the choice is "without limitation to a specific material."
  • Claim 25 (remove and re-apply an inner molding after inspection): Lo + Toyoda. Motivation: salvaging a good subassembly rather than scrapping it is a well-understood cost-reduction objective, and the patent concedes it ("by enabling a defective molding to be replaced without requiring the discard of a framework and its associated elements … substantial costs can be saved").

3.2 Independent claim 1 — vulnerable, but the strongest known combination failed at institution

Claim 1 adds two hard requirements over claim 16: (i) a second inner molding covering all/substantially all of the first inner molding; and (ii) an outer molding covering all/substantially all of the second.

Combination proposed by Petitioner: Anderson (primary) + Downey (secondary), + Huang / Handbook of TPE / Toyoda / Azuma / Brennan for dependents.

• Petitioner mapped Anderson's filler material 44 (FIGS. 7g/7h) — filling gaps underneath an already-deposited coating and covering all/substantially all of it — onto element 1C ("second inner molding"), with Anderson's outer shell coating over the filler as the outer molding, and Downey supplying the wearable/user-contact context. See Fitbit's Rehearing Request, Paper 16, which sets out the whole theory in detail.
• The Board did not institute on claims 1–15 and denied rehearing (Paper 18, Oct. 31, 2016). Read fairly, the Board at the threshold was unpersuaded that Anderson's item 44 covered "all or substantially all" of the underlying layer, and that Anderson taught the discrete second inner molding element.

My independent assessment — where a § 103 challenge to claim 1 should be re-aimed. The Board's rejection of the Anderson theory is not a holding on the merits of claim 1, nor does it foreclose a differently-supported § 103 case. The missing element — a second, discrete molding layer applied over a first encapsulating layer, with a seal formed between them — is supplied directly and expressly by DE 102010039329 A1, whose stated object is exactly "an overmolding method for a sensor device … which ensures improved tightness … with simultaneously improved positional accuracy," achieved by (1) fully enclosing a sensor module in a first medium and (2) overmolding with a second medium to form a sealing connection. A proposed ground of:

Lo + DE 102010039329 A1 + Downey (+ Anderson for the "all or substantially all" coverage teaching, + US 2011/0213225 for the UV-cure/low-temperature protection of sensitive sensor electronics)

would map 1A→Lo, 1B→Lo/US 2011/0213225, 1C→DE 102010039329, 1D→Lo/Downey. I have not seen this exact combination litigated, so I present it as an analyst's construction, not an adjudicated result.

3.3 Motivation to combine (why a POSITA would have done this)

Under KSR, the motivation can come from the problem itself, from the references, or from market/design pressure. Here there are four independent, cumulative rationales:

1. The problem the patent admits. The specification's own background states that "sensitive electronic components such as printed circuit board assemblies ('PCBA'), sensors, and computer memory … can be significantly damaged or destroyed during manufacturing processes where protective overmoldings … occurs using techniques such as injection molding." The identical problem is stated in DE 102010039329's background and in Abbott's US 2011/0213225 (shielding temperature‑sensitive sensor electronics). Same problem → same solution type is the strongest KSR rationale available.
2. Multi‑shot molding is a known, off-the-shelf technique. The patent is classified in B29C 45/16 ("Making multilayered or multicoloured articles") and B29C 45/14 ("incorporating preformed parts or layers … injection moulding around inserts"). Two‑shot and insert molding were routine plastics practice; layering successive moldings with different properties is a finite, predictable set of solutions.
3. Co-molding for differentiated properties is expressly taught in the field. Bodkin (invoked in the related Otter proceeding) teaches co-molding to "incorporate different properties, colors, textures, shapes, or other characteristics" — the exact objective of an inner structural/protective molding plus an outer cosmetic/user-contact molding.
4. Skin contact drives the outer-layer material choice. A wearable band's outermost layer necessarily touches the user (claim 1's "configured to be positioned in contact with the user"). Selecting anti-bacterial/medical-grade/oleophobic outer materials for a wearable is ordinary design practice, not invention; the patent concedes all of these properties are conventional (see below).

There is no teaching away: no reference criticizes applying more than one molding layer; to the contrary, DE 102010039329 and the multi‑shot art teach that a second overmold improves sealing.

3.4 Dependent claims — element-by-element mapping

4. Secondary considerations and the patentee's counterarguments

1. No showing of unexpected results, long-felt need, or failure of others appears anywhere in the IPR record. The only recognised secondary-consideration-adjacent evidence was Jawbone's expert declaration (Ex. 2001, Young), directed at validity of claims 16–26 — and it did not carry the day.
2. The best patentee argument was claim construction, not inventiveness. Jawbone argued "covers all or substantially all" means complete coverage / encasing, while Fitbit argued it means "on top of" (Demonstratives, Paper 34). This is a scope fight. Even on Jawbone's narrower reading, DE 102010039329's "complete enclosure" by the first medium plus overmolding with a sealing second medium independently satisfies it — which is why the construction dispute does not save the claims.
3. Claim 1's escape was procedural, not merits. Claims 1–15 survived only because the Board exercised its § 314(a) discretion not to institute and then denied rehearing. That is not a holding of non-obviousness, and it does not create issue preclusion. A future challenger with a cleaner second-layer reference (DE 102010039329 is my candidate) is not foreclosed.

5. Conclusions

1. Claims 16–26 are obvious (indeed, claim 16 and claims 17–19, 23, 26 were held anticipated by Lo, the stronger finding), as adjudicated in IPR2016‑00607. Lo alone disposes of claim 16; Lo+Huang, Lo+Handbook of Thermoplastic Elastomers, and Lo+Toyoda dispose of claims 20–22, 24, and 25 respectively.
2. Claim 1 and its dependents 2–15 are vulnerable to § 103 but have not been adjudicated. The Anderson+Downey + secondary-reference combination that Petitioner advanced was refused institution and rehearing was denied — so on the existing record, claim 1 has not been shown obvious. My recommendation for a re-aimed challenge is Lo + DE 102010039329 A1 + Downey, optionally with US 2011/0213225 A1 (Abbott) for the low-temperature/UV-cure protective-material element and Anderson for the "all or substantially all" coverage teaching.
3. Motivation to combine is strong and multi-sourced (patentee's admitted problem; routine multi-shot molding under B29C 45/14 & 45/16; field-known co-molding for differentiated properties; skin-contact material selection).
4. The protective-property dependent claims (2–6, 15, 18–22, 26) are near-confessionally obvious, because the specification itself recites every one of those properties as a conventional coating characteristic available "without limitation."

6. Explicit uncertainties (do not treat as verified)

• I could not retrieve the full citations for Lo, Anderson, Downey, Huang, Toyoda, Azuma, or Brennan in this session. Their roles and the grounds are verified from the IPR papers; their identities are not. Pull Exhibits 1003–1010 before relying on any specific mapping.
• I did not locate a § 103 analysis of claims 1–15 anywhere; the Board's non-institution is not such an analysis. Anything I say about claim 1 above is my own construction, not an adjudicated holding.
• The DE 102010039329 A1 and US 2011/0213225 A1 combinations I propose are not in the IPR record and are presented as analyst hypotheses; I have not verified the references' priority dates against the June 10, 2011 critical date beyond what the search snippets show (DE 102010039329 was filed 2010 and its own background confirms two-stage sensor overmolding was already known; US 2011/0213225 was filed Aug. 31, 2010, which would make it § 102(e) art).
• The status of the patent remains Expired – Fee Related, with anticipated expiration June 10, 2031.

Key sources:

• IPR2016‑00607 Final Written Decision (Aug. 15, 2017)
• Petitioner Fitbit's Demonstratives (Paper 34)
• Fitbit Petition (Feb. 10, 2016)
• Fitbit Rehearing Request on claims 1–15 (Aug. 30, 2016)
• US8529811 granted PDF (References Cited)
• DE 102010039329 A1 — Overmolding method for a sensor device
• US 2011/0213225 A1 — Medical devices and methods (Abbott Diabetes Care)
• Patexia IPR2016‑00607 outcome summary